H2 receptor antagonists vs sucralfate
ICU mortality · people admitted to intensive care units
H2 receptor antagonists showed no clear difference in all‐cause mortality in ICU compared with sucralfate (low certainty).
1 finding from 1 review
- Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes onlyRR 1.09 [0.95, 1.24]21 studies · 3178 participantsLow